[Progress in the area of drug development. 12].
D000477:Alkylating Agents; D000818:Animals; D000903:Antibiotics, Antineoplastic; D001249:Asthma / Q000188:drug therapy; D002317:Cardiovascular Agents; D002492:Central Nervous System Depressants; D004232:Diuretics; D004358:Drug Therapy; D005100:Expectorants; D006728:Hormones; D006801:Humans; D000960:Hypolipidemic Agents; D008660:Metabolism / Q000187:drug effects; D010276:Parasympatholytics; D010600:Pharmacology; D011838:Radiation-Sensitizing Agents; D012216:Rheumatic Diseases / Q000188:drug therapy
D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D002317:Cardiovascular Agents; D002492:Central Nervous System Depressants; D004232:Diuretics; D005100:Expectorants; D006728:Hormones; D000960:Hypolipidemic Agents; D010276:Parasympatholytics; D011838:Radiation-Sensitizing Agents
Fortschritte auf dem Gebiet der Arzneimittelentwicklung. Teil 12.